Follow the latest coverage, related explainers and connected technology stories.
Medtronic received clearance from the U.S. Food and Drug Administration to use the LigaSure vessel-sealing tool with the Hugo robotic surgery system. The decision adds a technology used in more than 45 million procedures to a platform seeking to compete with Intuitive’s presence in robotic surgery.
Medtronic has launched a share-exchange offer that enables the separation of up to 80.1% of MiniMed, after the diabetes technology company went public in March. The offer could lead Medtronic to relinquish its remaining stake, while the parent company focuses its investments on cardiovascular care, neuroscience, and surgery.
The Centers for Medicare and Medicaid Services approved coverage for transcatheter aortic valve replacement for patients with severe aortic stenosis even without symptoms. Analysts expect Edwards Lifesciences to benefit particularly, while evidence continues to be collected on this patient group.